vascepa
(icosapent ethyl)Amarin Pharma Inc.
Usage: VASCEPA (icosapent ethyl) is indicated to reduce the risk of cardiovascular events in patients with elevated triglyceride levels (≥ 150 mg/dL) and established cardiovascular disease or diabetes with additional risk factors, and to lower triglyceride levels in adults with severe hypertriglyceridemia (≥ 500 mg/dL).